Press coverage about CIGNA (NYSE:CI) has trended somewhat positive this week, Accern Sentiment reports. The research group ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. CIGNA earned a news impact score of 0.22 on Accern’s scale. Accern also assigned news stories about the health services provider an impact score of 46.8052274080848 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
These are some of the media headlines that may have effected Accern Sentiment Analysis’s analysis:
- Cigna names new market president for Georgia and Alabama (bizjournals.com)
- Norwalk Health Department Offers Flu Shots, Ways To Stay Healthy (patch.com)
- Analysts Anticipate CIGNA Co. (CI) Will Post Quarterly Sales of $11.01 Billion (americanbankingnews.com)
- Ghetto Film School gives young filmmakers chance at stardom (pix11.com)
- Cigna Corporation Announces Appearance at the Barclays Global Healthcare Conference (finance.yahoo.com)
CIGNA (NYSE:CI) traded up $0.25 on Thursday, hitting $191.90. The stock had a trading volume of 1,099,476 shares, compared to its average volume of 1,540,000. CIGNA has a 52 week low of $143.85 and a 52 week high of $227.13. The firm has a market capitalization of $47,310.00, a PE ratio of 21.02, a price-to-earnings-growth ratio of 1.16 and a beta of 0.44. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.39 and a current ratio of 0.37.
A number of research analysts recently issued reports on the company. Morgan Stanley increased their price objective on CIGNA from $195.00 to $223.00 and gave the stock an “overweight” rating in a report on Friday, November 3rd. Oppenheimer raised their price target on CIGNA to $237.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. Royal Bank of Canada restated an “outperform” rating and issued a $220.00 price target (up from $185.00) on shares of CIGNA in a research note on Friday, November 3rd. Goldman Sachs Group initiated coverage on CIGNA in a research note on Wednesday, January 3rd. They issued a “neutral” rating and a $247.00 price target for the company. Finally, Credit Suisse Group initiated coverage on CIGNA in a research note on Thursday, November 2nd. They issued an “outperform” rating and a $219.00 price target for the company. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $210.12.
In other news, EVP John M. Murabito sold 28,037 shares of the firm’s stock in a transaction that occurred on Wednesday, January 10th. The stock was sold at an average price of $205.68, for a total value of $5,766,650.16. Following the completion of the sale, the executive vice president now directly owns 60,290 shares of the company’s stock, valued at $12,400,447.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director William D. Zollars sold 212 shares of the firm’s stock in a transaction that occurred on Wednesday, January 10th. The shares were sold at an average price of $205.68, for a total value of $43,604.16. Following the completion of the sale, the director now directly owns 13,500 shares of the company’s stock, valued at $2,776,680. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 64,663 shares of company stock valued at $13,329,903. Insiders own 1.30% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was first posted by BBNS and is owned by of BBNS. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://baseballnewssource.com/markets/cigna-ci-earning-somewhat-positive-news-coverage-study-finds/1905523.html.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.